The sequencing reagents market is estimated to secure a valuation of US$ 6.7 Billion in 2023 and is estimated to rise to US$ 13.4 Billion by 2033. The market is anticipated to grow at a CAGR of 7.2% during the forecast period. The factors accelerating the demand for sequencing reagents are as follows-
The raid development in sequencing technology
Increased use of next-generation sequencing technology
Increased rate of genetic testing
Increasing demand for diagnostic & therapeutic applications
The growing research & development activities
Technological advances in healthcare
Increased application of Nanopore and single molecule real-time sequencing technology
Presence of government supportive programs
North America is expected to dominate the sequencing reagents market during the forecast period.
Increased application of sequencing reagents in oncology, virology, forensics, RNA sequencing, and clinical investigation is likely to drive the growth of the sequencing reagents market growth during the forecast period. Increased adoption of third-generation sequencing is likely to augment the sequencing reagents market.
Growing technological advances in sequencing technology such as improvement in sequencing accuracy have led to the development of growth in the sequencing platform, which further drives the growth of the sequencing reagents market
The global sequencing reagents market is expected to be dominated by North America due to the rising prevalence of chronic disease and increased technological advancements and research & development activities in the healthcare sector.
Europe is expected to account for the highest market share of the sequencing reagents market in the coming years owing to the increased focus on personalized medicine and high healthcare spending in countries like United Kingdom and Germany. Asia Pacific is expected to be the fastest-growing region in the sequencing reagents market. Increased research & development activities in the region are driving market growth in Asia Pacific.
The key players operating in a sequencing reagent market are Thermo Fisher Scientific, Inc, Illumina Inc, QAIGEN, BGI, Pacific Biosciences of California Inc, F. Hoffmann-La Roche AG, Oxford Nanopore Technology, Agilent Technology, Inc, Fluidigm Corporation ArcherDX Inc, Takara Bio Inc, Bioline among other.
The sequencing reagents market is highly fragmented in nature, Manufacturer are focusing on technological innovation for speeding up the diagnosis of the sequencing reagents market. Also, the market players are involved in joint ventures, partnerships, and mergers. All these companies offer a range of sequencing reagents including library preparation kits, sequencing kits, and reagents.
For instance, in March 2022- Thermo Fisher Scientific today launch CV-IVD marked on Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform that delivers results in a single day. It is specifically designed to use in clinical laboratories.
The market for sequencing reagents is expected to flourish during the forecast period owing to the increase in demand for NGS technology and the expanding application of sequencing in various fields including personalized medicine, and drug discovery. Additionally, the advances in sequencing technology and the development of new sequencing platforms are expected to further drive the growth of the sequencing reagents market. With the increased demand for sequencing reagents, start-ups are entering the market with innovative products and services.
For instance, founded in 2021 - D-Nome is the developer of reagents and kits for molecular diagnosis. They develop diagnostic reagents on the basis of proprietary innovative reagent technology for the genomic application. The product range includes D-LAMP PCR enzyme mix and D-LAMP genome sequencing reagents.
Data Point
Key statistics
Expected Market value in 2023
US$ 6.7 Billion
Projected Market Value in 2033
US$ 13.4 Billion
Growth Rate (2023 to 2033)
CAGR of 7.2%
Demand for sequencing reagents market will witness steady recovery in the short-term, with an optimistic growth outlook in the long run.
The increase in demand for diagnostic and therapeutic application will provide momentum to the industry, however, social and ethical concerns related to sequencing methods is likely to hinder the market growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What is Driving Demand for Sequencing Reagents?
Diminishing costs of genetic sequencing and growing levels of adoption for third-generation sequencing techniques is expected to propel the growth of the sequencing reagent market. Third-generation sequencing techniques streamline the workflow and reduce the overall time required for the preparation step. Furthermore, during ligation process and genome fragmentation, it helps to simplify and improves the data quality and overall workflow.
Additionally, the presence of appurtenant government programs has increased the expansion of ordering sequencing in distinguishing the genomic variations related to human diseases.
For example, in Gregorian calendar month 2018, NHS European nation, in partnership with the genetics European nation, sequenced a hundred thousand whole genomes from NHS patients to uncover new diagnoses and treatment for patients with cancer and rare inheritable diseases.
Moreover, a rise in funding from public and personal entities has supplemented the expansion of high output technology, later on enhancing demand for his or her various reagents. For example, in March 2018, the German analysis Foundation-funded USD seventeen.3 million to four new German sequencing centres to equip them with NGS technology.
Advancements in sequencing Techniques Likely to Augment Sequencing Reagents Market
The advancement of technology enables researchers to sequence the entire genome within a short period at a lower cost. Novel technologies like Nanopre and Single-Molecule Real-Time (SMRT) sequencing, have been developed for effective and efficient development of sequencing libraries.
This, not to mention the provision of recent commercial kits provides reagents for only a specific sequencing application, which further drives the market to grow.
The COVID-19 pandemic has caused havoc in the entire world. The healthcare crisis has brought an exceptional impact on businesses across all industries. During the outbreak, healthcare industries are hugely impacted due to global restrictions. However, the need for vaccination was the most important factor at the need of the hour.
Ongoing research and development for the COVID19 vaccine increased which in turn favoured the growth for sequencing reagents market.
Find your sweet spots for generating winning opportunities in this market.
USA and Canada Sequencing Reagents Market Outlook
The healthcare system of the USA is well-known for its advanced structure and spending. The USA has the benefit of catering to leading biotechnology sector market players over other countries and hence dominating the sequencing reagents market. The USA sequencing reagents market is set to trend on the historic pattern of bust and boom during the assessment period 2021 to 2031.
The country is home to some of the biggest pharma and biotechnology companies worldwide and is set to expand its business with high returns.
USA and Canada are one of the largest markets for sequencing reagents globally.
The countries have the highest rate of research and development among all the other countries resulting in a key region for the sequencing reagents market. Furthermore, well-established infrastructure, increasing adoption of novel sequencing technologies, and increasing healthcare expenditure are expected to fuel the sequencing reagents Market in this region.
Europe Demand Outlook for Sequencing Reagents
Europe’s biotech market attractive to investors: strong hot spots across geographies, modalities, and therapeutic areas; powerhouse research and industry expertise to support basic science and innovation; and an abundance of high-caliber talent and is likely to propel the growth of sequencing reagent market.
Cell and gene therapies (CGTs) and immunotherapies are the fastest-growing areas in the country and make Europe global powerhouse for scientific research in genomics.
Germany and United Kingdom are the most leading countries of the Europe region where spending on healthcare infrastructure is likely to be seen high. This creates opportunity for steady demand of sequencing reagent market to boost in long run.
Furthermore, it manufacturers and suppliers is to expand their business through merger and acquisitions and develop advanced technology applications for genomics.
For example, Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Who are the Key Manufacturers and Suppliers of Sequencing Reagents?
Some of the leading manufacturers and suppliers of Sequencing Reagents include
Thermo Fisher Scientific, Inc.
Illumina, Inc.
QIAGEN
BGI
Pacific Biosciences of California, Inc.
F. Hoffmann-La Roche AG
Oxford Nanopore Technologies
Agilent Technologies, Inc.
Fluidigm Corporation; ArcherDX, Inc.
Takara Bio Inc.
Bioline.
Key manufacturers are escalating their business through developments, collaborations and geographic expansions in emerging regions, in March 2019, Agilent Technologies introduced a new library preparation system for NGS technology called Magnis NGS Prep System which was designed to easily assay and complex multiple genes and genetic aberrations from genomic DNA.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.
The report also maps the qualitative impact of various market factors on market segments and geographies.
